LDX lumos diagnostics holdings limited

7.41%

2.9¢

As per above attached. IMO, LDX is cashed up.........has...

First 1029 Last

Share
Profile

Follow
Quest09

1,832 Posts.

174

13/12/24

11:52

Post #: 77034114
Share

Originally posted by Quest09: ↑

IMO, we can potentially gauge the likelihood of achieving a successful PLA code reimbursement outcome by generally gauging government and institutional support for LDX and its products.

As mentioned in the above attached, Microbial resistance to antibiotics (AMR) is a real, present and global problem which is being fought on a global scale by pretty much all govt of the world. On a global scale, we can see some significant global support in the fight against AMR.

Additionally, and more locally to the USA, LDX has already garnered support from BARDA (a subset of the USA Gov Department of Health) in the form of a USA $3 million dollar grant to support the LDX CLIA waiver (see images below). A potential total contract value of over USA $ 8 millions dollars is also on offer from BARDA.

IMO, if the USA Govt Department of Health and Human Services (BARDA) is supporting LDX in their work and products, then it is highly likely that other USA government departments and other USA medical institutions will also support LDX in their work and products (for example, IMO it would not make sensefor the American Medical Association (AMA) to not provide support if BARDA is already providing support).

So if we can assume that support from one USA government department would translate into support more broadly, then we can assume that the PLA code reimbursement should be successful. As such, IMO it is highly likely that the PLA code reimbursement will be granted as a contributing measure in the global fight against AMR.

The PLA reimbursement news is due at any moment.

Biomedical Advanced Research and Development Authority (BARDA)

BARDA had awarded LDX USA $2.98 million to support the CLIA waiver, with a potential total of USA $8.25 million available.

Expand

Originally posted by Quest09: ↑

From the recent quarterly report: "Cash balance of US $5.7 million as at 30 September 2024, prior to receipt of Retail Offer Proceeds of A$6.9 million."

Note - US $5.7 million = approx. AUD $8.7 million.

AUD $8.7 million cash on hand + AUD $6.9 million proceeds from retail offer = AUD $15.6 million dollars.

According to the quarterly, as of 30 September 2024, LDX has approx $15.6 million AUD cash balance on hand.

That also does not include the US $3.0 million grant that has been awarded for the CLIA waiver study (approx AUD $4.6 million).

If we include the grant, then cash available would be approx: AUD $20.2 million cash.
LDX current market cap is appprox: AUD $25 million

Very basic calculation, but IMO, it gives a very clear indication that LDX is currently significantly undervalued.

Expand

As per above attached. IMO, LDX is cashed up.........has multiple current revenue streams which are expected to improve over time.....has just achieved upto 8 million dollars in USA Govt funding...has also just achieved a USA Govt reimbursement to clinicians who buy and use the LDX FebriDx product, essentially meaning that clinicians are being paid to use this LDX product.

IMO, LDX is in a very strong fundamental position and is currently significantly undervalued.

Onwards and upwards.

=)

LDX Price at posting: 3.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MEM

Many are concerned about global falling birthrates. This diverse stock has solutions

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

MTM

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Almonty Industries – Now it is getting critical!

First 1029 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.9¢		Change 0.002(7.41%)		Mkt cap ! $21.70M

Open	High	Low	Value	Volume
2.8¢	2.9¢	2.8¢	$44.36K	1.538M

Buyers (Bids)

No.	Vol.	Price($)
2	104764	2.9¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	324100	5

View Market Depth

No.	Vol.	Price($)
2	104764	0.029
5	468600	0.028
3	218288	0.027
3	581461	0.026
7	641153	0.025

Price($)	Vol.	No.
0.030	324100	5
0.031	252105	5
0.032	51725	1
0.035	88000	1
0.037	493186	2

Last trade - 14.13pm 18/06/2025 (20 minute delay)

LDX (ASX) Chart

As per above attached. IMO, LDX is cashed up.........has...

Many are concerned about global falling birthrates. This diverse stock has solutions

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Almonty Industries – Now it is getting critical!

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

As per above attached. IMO, LDX is cashed up.........has...

Top Stories

Many are concerned about global falling birthrates. This diverse stock has solutions

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Almonty Industries – Now it is getting critical!

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News